CervoMed Inc.

NASDAQ: CRVO · Real-Time Price · USD
10.17
-0.02 (-0.20%)
At close: Aug 15, 2025, 3:59 PM
10.12
-0.49%
After-hours: Aug 15, 2025, 04:10 PM EDT

CervoMed Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-16.29M -2.17M -5.8M -24.1M
Depreciation & Amortization
n/a n/a n/a 93.42K
Stock-Based Compensation
1.41M 407.63K 461.35K 897.26K
Other Working Capital
49.2K 88.88K 300.78K -249K
Other Non-Cash Items
-1.21M -5.42M 2.39M 8.69M
Deferred Income Tax
n/a n/a n/a -443.89K
Change in Working Capital
-440.66K -261.36K 379.94K 356.37K
Operating Cash Flow
-16.53M -7.45M -2.57M -14.5M
Capital Expenditures
-3 -3 n/a n/a
Cash Acquisitions
n/a n/a n/a 4K
Purchase of Investments
-48.1M n/a -37.99M n/a
Sales Maturities Of Investments
19.44M n/a 25.75M n/a
Other Investing Acitivies
n/a 3.00 n/a n/a
Investing Cash Flow
-28.66M n/a -12.24M 4K
Debt Repayment
n/a n/a n/a 6M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 10.34M -5K -3.8M
Financial Cash Flow
46.4M 11.15M n/a 33.3M
Net Cash Flow
1.21M 3.7M -2.57M 18.8M
Free Cash Flow
-16.53M -7.45M -2.57M -14.5M